An observational study in Urinary Incontinence, sponsored by Mackay Medical College. Recruiting at 1 site in Taiwan. Open to female participants aged 20 Years to 100 Years. Per ClinicalTrials.gov, last updated 2023-08-04.
Sponsored by Mackay Medical College · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Urinary Incontinence with a site in Taiwan — 2 open to participants now, 2 under way, none of them phase 3. Urinary Incontinence · Taiwan.
Among the 13 studies in Urinary Incontinence with a site in Taiwan, this one is one of 4 that started in 2023, is one of 3 observational ones, and was the 9th registered.
988 studies on the registry are indexed under Urinary Incontinence; 184 are open to participants now.
Browse Urinary Incontinence studies →2 of the 13 studies in Urinary Incontinence with a site in Taiwan are open now. Recruiting first, the newest first:
National Taiwan University Hospital · Sites in Taiwan
Ages 18+ · Men only
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 113 Urinary Incontinence studies recruiting now, 63 (56%) set no upper age limit and 35 (31%) stop at 75 or younger; 15 take children under 18; 28 take healthy volunteers.
This study: 20 Years to 100 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 4 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 120 across 216 observational studies indexed under Urinary Incontinence.
Median enrollment 113 across the 10 interventional studies, 120 across the 3 observational. Of the 8 that completed or were terminated, 2 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 13 have an industry lead sponsor. The 9 most frequent:
Mackay Medical College is the lead sponsor of 20 studies on the registry; 8 are open to participants now.
Mackay Medical College has 1 study filed under Urinary Incontinence — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Urinary Incontinence with a site in Taiwan, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
To conduct a retrospective study to examine the effect of these conservative treatments to the symptoms and quality of life of patients with urinary incontinence. The investigators will use both subjective and objective assessment parameters, such as self-report symptoms, bladder diary, pad test and urodynamic study to access the improvement.
Urinary incontinence is a common problem among women. The main types include stress incontinence, urge incontinence, and overflow incontinence. Other underlying pathology, such as cancer or neurologic disease can also cause urinary incontinence. To limit the medical expenses and possible complications of surgical treatment, the current treatment guidelines recommend conservative treatment as the first choice. According to American Urological Association (AUA)/Society of Urodynamics, Female Pelvic Medicine \& Urogenital Reconstruction (SUFU) guidelines, the first-line treatment for non-neurologic overactive bladder should be behavioral therapy, such as bladder training, water restriction, and pelvic floor muscle training, physiological feedback, pessary, etc. Bladder training aims to increase the time interval between voids, and to increase the bladder capacity by self-adjusted schedules. Pelvic floor muscle training strengthens the pelvic floor muscles to provide urethral support to prevent urine leakage and suppress urgency. There is strong evidence that pelvic floor muscle training is beneficial for stress urinary incontinence.
The second-line treatment is medication, including anticholinergic drugs and ß3 adrenoceptor-acting agents. Anticholinergic drugs can reduce bladder detrusor contraction, and ß3 adrenoceptor-acting agents can relax the detrusor and increase bladder capacity.
Diagnosed at Mackay Memorial Hospital, the adult female patient was clinically assessed and diagnosed with urinary incontinence. Non-surgical treatments were administered, followed by subsequent monitoring and follow-up.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Data obtained before and after the training.
Procedure: BT
Data obtained before and after the training.
Procedure: bPFMT
Data obtained before and after the training.
Procedure: iVES
Data obtained before and after the training.
Procedure: BT + bPFMT
Data obtained before and after the training.
Procedure: BT + iVES
Data obtained before and after the training.
Procedure: bPFMT + iVES
A program of BT (including exercise and muscle training)
A bPFMT program at home
An iVES program at home
Combination of BT and bPFMT
Combination of BT and iVES
Combination of bPFMT and iVES
Urodynamic study (intravesical pressure)
intravesical pressure (cmH2O)
Time frame: form the baseline to the post-treatment measurement (about 6 month post)
Urodynamic study (abdominal pressure)
abdominal pressure (cmH2O)
Time frame: form the baseline to the post-treatment measurement (about 6 month post)
Urodynamic study (detrusor pressure)
detrusor pressure (cmH2O)
Time frame: from the baseline to the post-treatment measurement (about 6 month post)
Urodynamic study (Infused volume)
infused volume (ml)
Time frame: from the baseline to the post-treatment measurement (about 6 month post)
Urodynamic study (voided volume)
voided volume (ml)
Time frame: from the baseline to the post-treatment measurement (about 6 month post)
Pad test
The weight of Pad (g) before and after testing
Time frame: from the baseline to the post-treatment measurement (about 6 month post)
Bladder diary (voiding frequency)
the daily voiding frequency (times)
Time frame: from the baseline to the post-treatment measurement (about 6 month post)
Bladder diary (voiding volume)
the daily voiding volume (ml)
Time frame: from the baseline to the post-treatment measurement (about 6 month post)
Questionaire (UDI-6)
The urogenital distress inventory-6 (UDI-6)
Time frame: from the baseline to the post-treatment measurement (about 6 month post)
Questionaire (IIQ-7)
incontinence impact questionnaire-7 (IIQ-7)
Time frame: from the baseline to the post-treatment measurement (about 6 month post)
Plan to share: No — For we uncertain if this might violate personal information laws in our country.
Started Jan 2023 (actual). Primary completion is estimated for Dec 2023, 11 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mackay Medical College